Formulations and methods for treating rhinosinusitis
US8309061B2 · kind B2 · utility
13Cited by
19References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 12, 2005 |
| Grant date | Nov 13, 2012 |
| Priority date | — |
| Expiry date | Oct 14, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention involves methods and formulations for treating or preventing rhinosinusitis, including but not limited to, bacterial-induced, viral-induced and/or fungus-induced rhinosinusitis in mammals, and/or rhinosinusitis not induced by an infective agent, such as bacteria, fungus or virus. In one embodiment, the formulation of the present invention comprises an anti-inflammatory agent (e.g. fluticasone propionate) having a specific particle size distribution profile. The formulation may also comprise an antifungal agent, antibiotic or antiviral agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.